Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

Alvarez-Larran, A; Garrote, M; Ferrer-Marin, F; Perez-Encinas, M; Mata-Vazquez, MI; Bellosillo, B; Arellano-Rodrigo, E; Gomez, M; Garcia, R; Garcia-Gutierrez, V; Gasior, M; Cuevas, B; Angona, A; Gomez-Casares, MT; Martinez, CM; Magro, E; Ayala, R; del Orbe-Barreto, R;...